Samsung takes on clinical manufacturing of Ichnos’ mAb candidate 06-Nov-2019 By Vassia Barba Samsung continues an agreement formerly signed with Glenmark to manufacture Ichnos’ mAb treatment candidate for atopic dermatitis, as the product enters Phase III clinical trials.